tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

APGE Stock Latest News

Wayfair upgraded, Instacart initiated: Wall Street’s top analyst calls
The FlyWayfair upgraded, Instacart initiated: Wall Street’s top analyst calls
4d ago
W
HSY
Apogee Therapeutics price target raised to $116 from $109 at Craig-Hallum
PremiumThe Fly
Apogee Therapeutics price target raised to $116 from $109 at Craig-Hallum
5d ago
APGE
Aligos Therapeutics initiated with a Buy at UBS
PremiumThe Fly
Aligos Therapeutics initiated with a Buy at UBS
5d ago
IVA
KOD
Apogee Therapeutics initiated with a Peer Perform at Wolfe Research
PremiumThe Fly
Apogee Therapeutics initiated with a Peer Perform at Wolfe Research
5d ago
APGE
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
5d ago
F
AMD
Apogee Therapeutics price target raised to $84 from $81 at BofA
PremiumThe FlyApogee Therapeutics price target raised to $84 from $81 at BofA
5d ago
APGE
Apogee Therapeutics: Upgraded Outlook on Zumilokibart’s Superior Asthma Data, Dual-Label Potential, and Strengthened Buy Thesis
Premium
Ratings
Apogee Therapeutics: Upgraded Outlook on Zumilokibart’s Superior Asthma Data, Dual-Label Potential, and Strengthened Buy Thesis
5d ago
APGE
Apogee Therapeutics price target raised to $137 from $128 at BTIG
Premium
The Fly
Apogee Therapeutics price target raised to $137 from $128 at BTIG
5d ago
APGE
Apogee Therapeutics: Differentiated IL-13 Strategy, Durable Efficacy, and 2026 Catalysts Underpin Reaffirmed Buy Rating
PremiumRatings
Apogee Therapeutics: Differentiated IL-13 Strategy, Durable Efficacy, and 2026 Catalysts Underpin Reaffirmed Buy Rating
5d ago
APGE
Apogee Therapeutics price target raised to $133 from $95 at Stifel
PremiumThe Fly
Apogee Therapeutics price target raised to $133 from $95 at Stifel
5d ago
APGE
Apogee Therapeutics Stock (APGE) Plunges despite ‘Positive’ Asthma Drug Trial
PremiumMarket News
Apogee Therapeutics Stock (APGE) Plunges despite ‘Positive’ Asthma Drug Trial
6d ago
JNJ
APGE
Apogee Therapeutics Reports Positive Phase 1b Asthma Results
PremiumCompany Announcements
Apogee Therapeutics Reports Positive Phase 1b Asthma Results
6d ago
8K
APGE
Apogee Therapeutics reports ‘positive’ results from Phase 1b zumilokibart trial
PremiumThe FlyApogee Therapeutics reports ‘positive’ results from Phase 1b zumilokibart trial
6d ago
APGE
J&J failure likely a ‘clearing event’ for Apogee Therapeutics, says BTIG
Premium
The Fly
J&J failure likely a ‘clearing event’ for Apogee Therapeutics, says BTIG
13d ago
JNJ
APGE
Apogee Therapeutics price target lowered to $81 from $82 at BofA
Premium
The Fly
Apogee Therapeutics price target lowered to $81 from $82 at BofA
24d ago
APGE
Apogee Therapeutics initiated with an Overweight at Stephens
PremiumThe Fly
Apogee Therapeutics initiated with an Overweight at Stephens
26d ago
APGE
3 ‘Strong Buy’ Stocks to Buy Today, 12/10/2025, According to Top Analysts
PremiumMarket News
3 ‘Strong Buy’ Stocks to Buy Today, 12/10/2025, According to Top Analysts
1M ago
AMZN
APGE
Apogee Therapeutics initiated with a Buy at Deutsche Bank
PremiumThe Fly
Apogee Therapeutics initiated with a Buy at Deutsche Bank
1M ago
APGE
Apogee Therapeutics initiated with a Buy at Deutsche Bank
PremiumThe Fly
Apogee Therapeutics initiated with a Buy at Deutsche Bank
1M ago
APGE
Buy Rating for Apogee Therapeutics: Strong Financials and Promising Pipeline Drive Positive Outlook
PremiumRatingsBuy Rating for Apogee Therapeutics: Strong Financials and Promising Pipeline Drive Positive Outlook
2M ago
APGE
Apogee Therapeutics Reports Q3 2025 Financial Progress
Premium
Company Announcements
Apogee Therapeutics Reports Q3 2025 Financial Progress
2M ago
APGE
Positive Buy Rating for Apogee Therapeutics Driven by Promising Clinical Trials and Strategic Advancements
Premium
Ratings
Positive Buy Rating for Apogee Therapeutics Driven by Promising Clinical Trials and Strategic Advancements
2M ago
APGE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >